Dr. Kamran Idrees

Surgical Oncologist at Vanderbilt University Medical Center

Dr. Kamran Idrees is a surgical oncologist at the Vanderbilt-Ingram Cancer Center, a part of Vanderbilt University Medical Center. He has a clinical focus in peritoneal malignancies, including peritoneal mesothelioma. His specialities include use of HIPEC with surgery.

doctor image

focus icon

Peritoneal Mesothelioma

location icon

Vanderbilt University Medical Center

2220 Pierce Avenue, Nashville, TN 37232

doctor image

More About Mesothelioma Specialist Dr. Kamran Idrees

Dr. Idrees joined Vanderbilt University Medical Center in 2012. He is a surgical oncologist with a focus on abdominal malignancies. One of his trademark specialties is experience with HIPEC and cytoreductive surgery.

This led to him starting the HIPEC program at Vanderbilt-Ingram Cancer Center.

“I am really interested in doing basic and translational science research for peritoneal malignancies, including mesothelioma,” Dr. Idrees said. “… In the cancer biology world, we have sort of ignored the peritoneal cavity.”

Dr. Idrees served as director of the peritoneal malignancies and HIPEC program until Dr. Deepa Magge joined in 2020. She now leads the program.

Similar to Dr. Magge, Dr. Idrees is a fellowship graduate of University of Pittsburgh Medical Center. This is one of the best HIPEC programs in the world, with an impressive volume of peritoneal mesothelioma cases.

Dr. Idrees has held many titles at Vanderbilt University Medical Center. They include:

  • Chief in the Division of Surgical Oncology and Endocrine Surgery
  • Director of Pancreatic and Gastrointestinal Surgical Oncology
  • Assistant professor of surgery
  • Associate professor of cancer research
Degree icon

Medical Degrees and Residencies

    • Medical Degree from the Aga Khan University Medical College located in Karachi, Pakistan, 1999
    • Research fellowship in surgical oncology at Memorial Sloan Kettering Cancer Center, 2006
    • Residency in general surgery at the University of Alabama at Birmingham, 2008
    • Fellowship in surgical oncology at the University of Pittsburgh Medical Center, 2011
Accomplishments icon

Certifications and Memberships

    • Certified by the American Board of Surgery
    • Recipient of a National Institutes of Health Clinical and Translational Science Award
    • Only surgeon in Tennessee who is a member of the American Society of Peritoneal Surface Malignancy

Get Connected to Dr. Kamran Idrees

Get Connected to Dr. Kamran Idrees - Form Image

Dr. Idrees is a highly regarded peritoneal mesothelioma specialist with Vanderbilt-Ingram Cancer Center. He led the HIPEC and peritoneal malignancies program for eight years and remains a valued member of the team.

Why Choose Dr. Idrees?

  • Experience performing HIPEC surgery for patients
  • Patient selection process to improve survival after surgery
  • Advocate for immunotherapy and other options








Diagnosis:


Inspiration for HIPEC Program at Vanderbilt

When Dr. Idrees did his residency in general surgery at the University of Alabama at Birmingham, the hospital didn’t have a HIPEC program. This is despite the incidence of mesothelioma being high in Alabama.

He brought HIPEC to the Tennessee medical center in 2012. Since peritoneal mesothelioma is so rare, doctors often rely on Dr. Idrees for help.

“I think there are referring physicians who would call us to get our opinions on how to manage the patients,” he said.

Dr. Idrees said a mesothelioma diagnosis isn’t easy for anyone, including the family members and physicians. However, he’s up to the task.

“With this kind of disease, we realize a cure might not be possible,” he said. “Whatever we can do to improve their quality of life and add to their quantity of life is great.”

Strategy for Patient Selection

Dr. Idrees is integral in patient selection for HIPEC surgery. He and Dr. Magge are in unison for how the program determines eligibility.

“This is an extremely rare diagnosis,” he said. “Usually, the diagnosis is made elsewhere. So here at Vanderbilt, we get the slides and get them reviewed by pathologists.”

Cell type often determines candidacy. Epithelioid cells are easier to resect. Sarcomatoid cells are much tougher.

Immunotherapy is an option for patients, either with surgery or when resection isn’t feasible.

“We are looking at the cell composition of these patients,” he said, noting how much treatment has evolved.

If you’re interested in Dr. Idrees as your surgical oncologist, we can help set up a consultation. Contact our patient advocate team, which includes a registered nurse. They’ll help you schedule a meeting, with virtual options available.

Sources & Author

Devin Goldan image

About the Writer, Devin Golden

Devin Golden is the content writer for Mesothelioma Guide. He produces mesothelioma-related content on various mediums, including the Mesothelioma Guide website and social media channels. Devin's objective is to translate complex information regarding mesothelioma into informative, easily absorbable content to help patients and their loved ones.